Unews World
The U.S. Food and Drug Administration (FDA) has made a major move in heart health care by approving Rybelsus, the first oral GLP-1 receptor agonist, which helps to manage cardiovascular risks. Up until now, Rybelsus was known as a diabetes medication and was only taken in cases of increased blood sugar levels, in adults with type 2 diabetes. But with …
Read More »FDA approves pill which can prevent heart attack, stroke by reducing inflammation: How it works – The Times of India
